ImmunityBio (IBRX) Debt Ratio (2014 - 2026)

ImmunityBio (IBRX) has 13 years of Debt Ratio data on file, last reported at 0.63 in Q1 2026.

• Debt Ratio for Q1 2026 came in at 0.63, down 35.9% year-over-year; the trailing twelve-month figure through Mar 2026 was 0.63 (down 35.9% YoY), and the FY2025 annual result was 0.65, down 12.92% from the prior year.
• Debt Ratio fell to 0.63 in Q1 2026 per IBRX's latest filing, from 0.65 in the prior quarter.
• Over five years, Debt Ratio peaked at 1.11 in Q3 2023 and troughed at 0.31 in Q4 2023.
• A 5-year average of 0.74 and a median of 0.74 in 2024 frame the typical range for Debt Ratio.
• The sharpest annual moves came in 2022 and 2024: Debt Ratio tumbled 47.21% in 2022, then jumped 141.07% in 2024.
• A 5-year view of Debt Ratio shows it stood at 1.06 in 2022, then sank by 70.87% to 0.31 in 2023, then jumped by 141.07% to 0.74 in 2024, then decreased by 12.92% to 0.65 in 2025, then declined by 3.33% to 0.63 in 2026.
• Business Quant data shows IBRX's Debt Ratio at 0.63 in Q1 2026, 0.65 in Q4 2025, and 0.61 in Q3 2025.